SCHEMBL27344840

SCHEMBL27344840

CNNC1CN(C(=O)OC(C)(C)C)CC1C

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
USP30 Q70CQ3 2/20 0.47
NR1H2 P55055 1/20 0.45
USP2 O75604 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
EPHX1 P07099 1/20 0.39
NAMPT P43490 1/20 0.39
HPGD P15428 1/20 0.38
RORC P51449 1/20 0.38
EPHX2 P34913 1/20 0.38
KDM4E B2RXH2 1/20 0.37
GPR119 Q8TDV5 1/20 0.37
SSTR4 P31391 1/20 0.37
PDE4B Q07343 1/20 0.36
RECQL P46063 1/20 0.36
PTPN2 P17706 1/20 0.36
PTPN1 P18031 1/20 0.36
PTPN6 P29350 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23931084 0.87 USP30 (0.49) USP30NR1H2USP2SMN1; SMN2EPHX1
SCHEMBL23931025 0.87 USP30 (0.49) USP30NR1H2USP2SMN1; SMN2EPHX1
SCHEMBL18471329 0.87 USP30 (0.49) USP30NR1H2USP2SMN1; SMN2EPHX1
SCHEMBL23931026 0.87 USP30 (0.49) USP30NR1H2USP2SMN1; SMN2EPHX1
SCHEMBL23931024 0.87 USP30 (0.49) USP30NR1H2USP2SMN1; SMN2EPHX1
SCHEMBL31208839 0.81 USP30 (0.47) USP30NR1H2USP2SMN1; SMN2EPHX1
SCHEMBL31209548 0.81 USP30 (0.47) USP30NR1H2USP2SMN1; SMN2EPHX1
SCHEMBL31208625 0.81 USP30 (0.47) USP30NR1H2USP2SMN1; SMN2EPHX1
SCHEMBL15764146 0.80 NR1H2 (0.58) USP30NR1H2USP2SMN1; SMN2EPHX1
SCHEMBL13801217 0.80 NR1H2 (0.58) USP30NR1H2USP2SMN1; SMN2EPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023235691-A1 BTK REDUCING MOLECULES FOR TREATMENT OF CANCERS AND IMMUNE SYSTEM DISORDERS ACCUTAR BIOTECHNOLOGY, INC. (US) 2023-12-07 WO disclosed